Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison

Medicine and Dentistry

• Coronary Artery Disease 100%
• Thrombosis 100%
• Heart Death 100%
• Everolimus 100%
• Target Lesion Revascularization 100%
• Target Lesion 100%
• Randomized Controlled Trial 50%
• Myocardial Infarction 50%
• Percutaneous Coronary Intervention 50%
• Coronary Stenting 50%
• Acute Coronary Syndrome 50%

Keyphrases

• Coronary Artery Disease 100%
• Bioresorbable Scaffold 100%
• Everolimus 100%
• Novolimus 100%
• Matched Comparison 100%
• Cardiac Death 13%
• Target Lesion Revascularization 13%
• Scaffold Thrombosis 13%
• Predilation 13%
• Target Lesion Failure 13%
• Randomized Controlled Trial 6%
• Clinical Presentation 6%
• Myocardial Infarction 6%
• Consecutive Patients 6%
• Percutaneous Coronary Intervention 6%
• Baseline Characteristics 6%
• Lesion Characteristics 6%
• Acute Coronary Syndrome 6%
• 1-year Outcome 6%
• Target Vessel 6%
• Propensity Matching 6%
• Real-world Clinical Practice 6%
• Coronary Artery Stenting 6%
• Everolimus-eluting 6%
• Practice Scenario 6%
• Scaffold Implantation 6%